NIH study identifies new targets for anti-malaria drugs
Researcher using blood extraction instrument.

Researchers have identified two key proteins that are needed for the deadliest malaria parasite to infect red blood cells and exit the cells after it multiplies. The finding could provide the basis of new targets for drug development against the Plasmodium falciparum, which is the species of parasite that causes the most malaria deaths worldwide, the researchers say.  Their study, which appears in Science, is partly funded by NHLBI.

Media Coverage